Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products The agreement will allow ...
The MarketWatch News Department was not involved in the creation of this content. Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its ...
India's rare disease policy sets a Rs. 50 lakh ceiling. Roche's Risdiplam costs Rs. 72 lakhs a year. A generic alternative ...
The Progeria Research Foundation (“PRF”), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gilford Progeria Syndrome (“Progeria”), and Forge Biologics, ...
Shares of firms like Tata Motors, RVNL, RIL, Sun Pharma, RailTel, Zydus Lifesciences, and others will be in focus on ...
Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a new genetic disease marked by premature aging and deficits in brain function.
Sick sinus syndrome (SSS) is a heart rhythm problem that affects your heart's natural pacemaker. You may develop symptoms of SSS like dizziness, fainting, and fatigue. Treatment may include lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results